Share

November 05, 2019; 93 (19) Editorial

Cognitive behavioral therapy in functional tremor

A promising treatment approach

Kirsten E. Zeuner, Christos Sidiropoulos
First published October 4, 2019, DOI: https://doi.org/10.1212/WNL.0000000000008438
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
261

Share

Article Information

vol. 93 no. 19 825-826
DOI: 
https://doi.org/10.1212/WNL.0000000000008438
PubMed: 
31586024
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published October 4, 2019.

Article Versions

Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Kirsten E. Zeuner, MD and
    2. Christos Sidiropoulos, MD
  1. Kirsten E. Zeuner, MD and
    2. Scientific Advisory Boards:

    1. Kirsten Zeuner has done medical advisory work for Merz Pharmaceuticals Inc and Ipsen.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Kirsten E. Zeuner has received lecture fees from Allergan, Ipsen and Merz Pharmaceuticals.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. My research has been supported by by Allergan, and with an unrestricted grant from Ipsen.

    Research Support, Government Entities:

    1. My research has been supported by the German Research Foundation, by the University of Schleswig Holstein, the Benign Essential Blepharospasmus Foundation

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Christos Sidiropoulos, MD
    3. Scientific Advisory Boards:

    1. Serving on the scientific advisory board of Abbvie and Boston Scientific both of them are commercial entities

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Movement Disorders Society, Travel Grant

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultancies for Medtronic and Boathouse Inc. on behalf of Global Kinetics Corporation, Manufacturer of the Personal Kinetigraph

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Neurocrine Pharmaceuticals

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. Michigan State University

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (K.E.Z.), Kiel University, Germany; and Department of Neurology and Ophthalmology (C.S.), Michigan State University, East Lansing.
  1. Correspondence
    Dr. Zeuner k.zeuner{at}neurologie.uni-kiel.de
View Full Text

Article usage

Article usage: October 2019 to April 2023

AbstractFullPdfSource
Oct 2019540442Highwire
Nov 20192804449Highwire
Dec 201963811Highwire
Jan 202090615Highwire
Feb 2020113516Highwire
Mar 20205407Highwire
Apr 202094310Highwire
May 20205105Highwire
Jun 202010168Highwire
Jul 20208713Highwire
Aug 20203224Highwire
Sep 20204329Highwire
Oct 20206124Highwire
Nov 20205839Highwire
Dec 20205918Highwire
Jan 20214505Highwire
Feb 20217029Highwire
Mar 20218505Highwire
Apr 202165211Highwire
May 202140115Highwire
Jun 20213604Highwire
Jul 20213910Highwire
Aug 20215630Highwire
Sep 20214110Highwire
Oct 20216220Highwire
Nov 20213922Highwire
Dec 20214032Highwire
Jan 20223410Highwire
Feb 20224211Highwire
Mar 20224100Highwire
Apr 20223830Highwire
May 20224010Highwire
Jun 20223301Highwire
Jul 20223001Highwire
Aug 20222511Highwire
Sep 20221900Highwire
Oct 20224123Highwire
Nov 20223110Highwire
Dec 20223100Highwire
Jan 20233501Highwire
Feb 20233610Highwire
Mar 20234640Highwire
Apr 20231830Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles